Jpmorgan Chase & CO Eargo, Inc. Transaction History

Jpmorgan Chase & CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.75 - $5.6 $649,636 - $4.85 Million	-866,182 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$3.3 - $7.28 $370,141 - $816,553	-112,164 Reduced 11.46%	866,182 $4.58 Million
Q4 2021 Feb 10, 2022	BUY	$4.6 - $10.21 $1.65 Million - $3.66 Million	358,078 Added 57.73%	978,346 $4.99 Million
Q3 2021 Nov 12, 2021	BUY	$6.59 - $38.71 $4.09 Million - $24 Million	620,268 New	620,268 $4.18 Million

33.4K

Ticker EAR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 39,411,000
Market Cap $2.78B
Description
Eargo, Inc., a medical device company, engages in enhancing the quality of life of people with hearing loss in the United States. The company markets and sells hearing aids. It sells its products direct-to-consumer and through omni-channel. The company was formerly known as Aria Innovations, Inc. and changed its name to Eargo, Inc. in November 2...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.